The role of tumor necrosis factor-alpha in stress-induced worsening of cerebral ischemia in rats

Neuroscience

Volumn 142, Issue 1, 2006, Pages 59-69

  Caso, J R ^a   Lizasoain, I ^a   Lorenzo, P ^a   Moro, M A ^a   Leza, J C ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

stress; stroke; TNFalpha

Indexed keywords

CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BIOACCUMULATION; BRAIN DAMAGE; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN TISSUE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE MARKER; DISEASE SEVERITY; IMMOBILIZATION STRESS; LIPID PEROXIDATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NITROSATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; STRESS;

ADAM PROTEINS; ANIMALS; ANTIBODIES; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; BRAIN INFARCTION; BRAIN ISCHEMIA; CORTICOSTERONE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; LIPID PEROXIDATION; MALE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, INBRED F344; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; STRESS; STRESS, PHYSIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748465894     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.06.009     Document Type: Article

References (67)

1. Ahmed N., de la Torre B., and Wahlgren N.G. Salivary cortisol, a biological marker of stress, is positively associated with 24-hour systolic blood pressure in patients with acute ischaemic stroke. Cerebrovasc Dis 18 (2004) 206-213
2. Arato M., Banki C.M., Nemeroff C.B., and Bissette G. Hypothalamic-pituitary-adrenal axis and suicide. Ann N Y Acad Sci 487 (1986) 263-270
3. Arribas J., Coodly L., Vollmer P., Kishimoto T.K., Rose-John S., and Massague J. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J Biol Chem 10 (1996) 11376-11382
4. Barone F.C., Arvin B., White R.F., Miller A., Webb C.L., Willette R.N., Lysko P.G., and Feuerstein G.Z. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28 (1997) 1233-1244
5. Baud V., and Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11 (2001) 372-377
6. Bax D.V., Messent A.J., Tart J., van Hoang M., Kott J., Maciewicz R.A., and Humphries M.J. Integrin alpha5beta1 and ADAM-17 interact in vitro and co-localize in migrating HeLa cells. J Biol Chem 279 (2004) 22377-22386
7. Black P.H. Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun 16 (2002) 622-653
8. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., Castner B.J., Stocking K.L., Reddy P., Srinivasan S., Nelson N., Boiani N., Scooley K.A., Gerhart M., Davis R., Fitzner J.N., Johnson R.S., Paxton R.J., March C.J., and Cerretti D.P. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385 (1997) 729-733
9. Botchkina G.I., Meistrell III M.E., Botchkina I.L., and Tracey K.J. Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia. Mol Med 3 (1997) 765-781
10. Bremner J.D., Southwick S.M., and Charney D.S. Animal models for the neurobiology of trauma. PTSD Res Q 2 (1991) 1-7
11. Brint S., Jacewicz M., Kiessling M., Tanabe J., and Pulsinelli W. Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J Cereb Blood Flow Metab 8 (1988) 474-485
12. Cárdenas A., Moro M.A., Leza J.C., O'Shea E., Dávalos A., Castillo J., Lorenzo P., and Lizasoain I. Up-regulation of TACE/ADAM17 after ischemic preconditioning is involved in brain tolerance. J Cereb Blood Flow Metab 22 (2002) 1297-1302
13. Colantonio A., Kasi S.V., and Ostfeld A.M. Depressive symptoms and other psychosocial factors as predictors of stroke in the elderly. Am J Epidemiol 136 (1992) 884-894
14. Connor T.J., Song C., Leonard B.E., Merali Z., and Anisman H. An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience 84 (1998) 923-933
15. Das N.P., and Ratty A.K. Studies on the effects of the narcotic alkaloids, cocaine, morphine, and codeine on nonenzymatic lipid peroxidation in rat brain mitochondria. Biochem Med Metab Biol 37 (1987) 258-264
16. De Cristóbal J., Moro M.A., Dávalos A., Castillo J., Leza J.C., Camarero J., Colado M.I., Lorenzo P., and Lizasoain I. Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischemia in rats. J Neurochem 79 (2001) 456-459
17. DeVries A.C., Joh H.D., Bernard O., Hattori K., Hurn P.D., Traystman R.J., and Alkayed N.J. Social stress exacerbates stroke outcome by suppressing Bcl-2 expression. Proc Natl Acad Sci U S A 98 (2001) 11824-11828
18. Dunn A.J., and Wang J. Cytokine effects on CNS biogenic amines. Neuroimmunomodulation 2 (1995) 319-328
19. Everson S.A., Roberts R.E., Goldberg D.E., and Kaplan G.A. Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med 158 (1998) 1133-1138
20. Feuerstein G.Z., Liu T., and Barone F.C. Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. Cerebrovasc Brain Metab Rev 6 (1994) 341-360
21. Gearing A.J.H., Beckett P., Christodoulou M., Churchill M., Clements J., Davidson A.H., Drummond A.H., Galloway W.A., Gilbert R., Gordon J.L., Leber T.M., Mangan M., Miller K., Nayee P., Owen K., Patel S., Thomas W., Wells G., Wood L.M., and Woolley K. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370 (1994) 555-557
22. Grippo A.J., Beltz T.G., Weiss R.M., and Johnson A.K. The effects of chronic fluoxetine treatment on chronic mild stress-induced cardiovascular changes and anhedonia. Biol Psychiatry 59 (2006) 309-316
23. Hayley S., Brebner K., Lacosta S., Merali Z., and Anisman H. Sensitization to the effects of tumor necrosis factor-alpha: neuroendocrine, central monoamine, and behavioral variations. J Neurosci 19 (1999) 5654-5665
24. Hayley S., Staines W., Merali Z., and Anisman H. Time-dependent sensitization of corticotropin-releasing hormone, arginine vasopressin and c-fos immunoreactivity within the mouse brain in response to tumor necrosis factor-alpha. Neuroscience 106 (2001) 137-148
25. Hill H.D., and Straka J.G. Protein determination using bicinchoninic acid in the presence of sulfhydryl reagents. Anal Biochem 170 (1988) 203-208
26. Holden R.J., and Pakula I.S. Tumor necrosis factor-alpha: is there a continuum of liability between stress, anxiety states and anorexia nervosa?. Med Hypotheses 52 (1999) 155-162
27. Hooper N.M., Karran E.H., and Turner A.J. Membrane protein secretases. Biochem J 321 (1997) 265-279
28. Hosomi N., Ban C.R., Naya T., Takahashi T., Guo P., Song X.Y., and Kohno M. Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia. J Cereb Blood Flow Metab 25 (2005) 959-967
29. Hunter A.J., Hatcher J., Virley D., Nelson P., Irving E., Hadingham S.J., and Parsons A.A. Functional assessments in mice and rats after focal stroke. Neuropharmacology 39 (2000) 806-816
30. Hurtado O., Cárdenas A., Lizasoain I., Boscá L., Leza J.C., Lorenzo P., and Moro M.A. Up-regulation of TNFalpha convertase (TACE/ADAM17) after oxygen-glucose deprivation in rat forebrain slices. Neuropharmacology 40 (2001) 1094-1102
31. Hurtado O., Lizasoain I., Fernández-Tomé P., Alvarez-Barrientos A., Leza J.C., Lorenzo P., and Moro M.A. TACE/ADAM17-TNF-α pathway in rat cortical cultures after exposure to oxygen-glucose-deprivation or glutamate. J Cereb Blood Flow Metab 22 (2002) 576-585
32. Jonas B.S., and Mussolino M.E. Symptoms of depression as a prospective risk factor for stroke. Psychosom Med 62 (2000) 463-471
33. Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haass C., and Fahrenholz E. Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci U S A 96 (1999) 3922-3927
34. Larson S.L., Owens P.L., Ford D., and Eaton W. Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from the Baltimore epidemiologic catchment area study. Stroke 32 (2001) 1979-1983
35. Leza J.C., Salas E., Sawicki G., Russell J.C., and Radomski M.W. The effect of stress on homeostasis in JCR:LA-cp rats: the role of nitric oxide. J Pharmacol Exp Ther 286 (1998) 1397-1403
36. Liu T., Clark R.K., McDonnell P.C., Young P.R., White R.F., Barone F.C., and Feuerstein G.Z. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25 (1994) 1481-1488
37. Madrigal J.L.M., Caso J., Hurtado O., Lizasoain I., Moro M.A., Lorenzo P., and Leza J.C. Brain oxidative markers in stress. Possible new drug targets against neuroinflammation. Curr Neuropharmacol 2 (2004) 183-189
38. Madrigal J.L.M., Caso J.R., De Cristóbal J., Cárdenas A., Leza J.C., Lizasoain I., Lorenzo P., and Moro M.A. Effect of subacute and chronic immobilisation stress on the outcome of permanent focal cerebral ischaemia in rats. Brain Res 979 (2003) 137-145
39. Madrigal J.L.M., Moro M.A., Lizasoain I., Lorenzo P., Fernández A.P., Rodrigo J., Boscá L., and Leza J.C. Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain. Neuropsychopharmacology 28 (2003) 1579-1588
40. Madrigal J.L.M., Hurtado O., Moro M.A., Lizasoain I., Lorenzo P., Castrillo A., Boscá L., and Leza J.C. The increase in TNFα levels is implicated in NF-κB activation and inducible nitric oxide synthase expression in brain cortex after immobilisation stress. Neuropsychopharmacology 26 (2002) 155-163
41. Maes M., Song C., Lin A., De Jongh R., Van Gastel A., Kenis G., Bosmans E., De Meester I., Benoy I., Neels H., Demedts P., Janca A., Scharpe S., and Smith R.S. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 10 (1998) 313-318
42. Moss M.L., Jin S.-L.C., Milla M.E., Burkhart W., Carter H.L., Chen W.J., Clay W.C., Didsbury J.R., Hassler D., Hoffman C.R., Kost T.A., Lambert M.H., Leesnitzer M.A., McCauley P., McGeehan G., Mitchell J., Moyer M., Pahel G., Rocque W., Overton L.K., Schoenen F., Saetón T., Su J.-L., Warner J., Willard D., and Becherer J.D. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385 (1997) 733-736
43. Munhoz C., Madrigal J.L.M., García-Bueno B., Pradillo J.M., Moro M.A., Lizasoain I., Lorenzo P., Scavone C., and Leza J.C. TNFα accounts for short-term persistence of oxidative status in rat brain after two weeks of repeated stress. Eur J Neurosci 20 (2004) 1125-1130
44. Nawashiro H., Martin D., and Hallenbeck J.M. Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. J Cereb Blood Flow Metab 17 (1997) 229-232
45. Nemeroff C.B., Widerlov E., Bissette G., Walleus H., Karlsson I., Eklund K., Kilts C.D., Loosen P.T., and Vale W. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226 (1984) 1342-1344
46. Nogawa S., Forster C., Zhang F., Nagayama M., Ross M.E., and Iadecola C. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci U S A 95 (1998) 10966-10971
47. Ohira T., Iso H., Satoh S., Sankai T., Tanigawa T., Ogawa Y., Imano H., Sato S., Kitamura A., and Shimamoto T. Prospective study of depressive symptoms and risk of stroke among Japanese. Stroke 32 (2001) 903-908
48. Olivenza R., Moro M.A., Lizasoain L., Lorenzo P., Fernández A.P., Rodrigo J., Boscá L., and Leza J.C. Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex. J Neurochem 74 (2000) 785-791
49. Planas A.M., Soriano M.A., Rodríguez-Farre E., and Ferrer I. Induction of cyclooxygenase-2 mRNA and protein following transient focal ischemia in the rat brain. Neurosci Lett 200 (1995) 187-190
50. Pradillo J.M., Romera C., Hurtado O., Cárdenas A., Moro M.A., Leza J.C., Dávalos A., Castillo J., Lorenzo P., and Lizasoain I. TNFR1 upregulation mediates tolerance after brain ischaemic preconditioning. J Cereb Blood Flow Metab 25 (2005) 193-203
51. Rosendahl M.S., Ko S.C., Long D.L., Brewer M.T., Rosenzweig B., Hedl E., Anderson L., Pyle S.M., Moreland J., Meyers M.A., Kohno T., Lyons D., and Lichenstein H.S. Identification and characterization of a pro-tumor necrosis factor-α-processing enzyme from the ADAM family of zinc metalloproteases. J Biol Chem 272 (1997) 24588-24593
52. Sapolsky R.M. Why stress is bad for your brain. Science 273 (1996) 749-750
53. Sapolsky R.M., and Pulsinelli W.A. Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science 229 (1985) 1397-1400
54. Schlöndorff J., Becherer J.D., and Blobel C.P. Intracellular maturation and localization of the tumour necrosis factor alpha convertase. Biochem J 347 (2000) 131-138
55. Sharif S.F., Hariri R.J., Chang V.A., Barie P.S., Wang R.S., and Ghajar J.B. Human astrocyte production of tumor necrosis factor-alpha, interleukin-1 beta and interleukin-6 following exposure to lipopolysaccharide endotoxin. Neurol Res 15 (1993) 109-112
56. Simons L.A., McCallum J., Friedlander Y., and Simons Y. Risk factors for ischemic stroke: Dubbo Study of the elderly. Stroke 29 (1998) 1341-1346
57. Solomon K.A., Pesti N., Wu G., and Newton R.C. Cutting edge: a dominant negative form of TNF-alpha converting enzyme inhibits proTNF and TNFRII secretion. J Immunol 163 (1999) 4105-4108
58. Sug Yoon S., and Byles J. Perceptions of stroke in the general public and patients with stroke: a qualitative study. BMJ 324 (2002) 1065-1068
59. Sug Yoon S., Heller R.F., Levi C., Wiggers J., and Fitzgerald P.E. Knowledge of stroke risk factors, warning symptoms, and treatment among an Australian urban population. Stroke 32 (2001) 1926-1930
60. Sugo N., Hurn P.D., Morahan M.B., Hattori K., Traystman R.J., and DeVries A.C. Social stress exacerbates focal cerebral ischemia in mice. Stroke 33 (2002) 1660-1664
61. Telner J.I., and Singhal R.L. Psychiatric progress. The learned helplessness model of depression. J Psychiatr Res 18 (1984) 207-215
62. Thoresen M., Bagenholm R., Loberg E.M., and Apriccna F. The stress of being restrained reduces brain damage after a hypoxic-ischaemic insult in the 7-day-old rat. Neuroreport 7 (1996) 481-484
63. Troxler R.G., Sprague E.A., Albanese R.A., Fuchs R., and Thompson A.J. The association of elevated plasma cortisol and early atherosclerosis as demonstrated by coronary angiography. Atherosclerosis 26 (1977) 151-162
64. Waldstein S.R., Siegel E.L., Lefkowitz D., Maier K.J., Brown J.R., Obuchowski A.M., and Katzel L.I. Stress-induced blood pressure reactivity and silent cerebrovascular disease. Stroke 35 (2004) 1294-1298
65. Watanabe N., Nakada K., and Kobayashi Y. Processing and release of tumor necrosis factor α. Eur J Biochem 253 (1998) 576-582
66. Wolff B., Grabe H.J., Volzke H., Ludemann J., Kessler C., Dahm J.B., Freyberger H.J., John U., and Felix S.B. Relation between psychological strain and carotid atherosclerosis in a general population. Heart 91 (2005) 460-464
67. Xie Q.-W., Kashiwabara Y., and Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 269 (1994) 4705-4708